Invetech provides assured pathways to automation for the global cell and advanced therapy market. Invetech works with clients to translate clinical processes into commercially successful products, from stepwise platforms to turnkey automation. Robust therapy production systems are configured to client processes using a combination of off-the-shelf solutions, proprietary technology platforms and custom in-house engineering. Invetech and client teams work collaboratively to meet commercial, quality and therapeutic objectives. Invetech has over 17 years’ experience developing automated closed processing for regenerative medicine products, with over 60 projects delivered worldwide, powered by 300 technical personnel across Melbourne, San Diego and Boston facilities.